Gestgain SR 200 Tablet contains 200 mg of natural micronized progesterone, a bioidentical hormone essential for regulating various physiological processes related to the female reproductive system. This sustained-release formulation ensures a gradual and consistent release of progesterone, optimizing therapeutic efficacy and minimizing fluctuations in hormone levels. Progesterone plays a critical role in supporting the luteal phase of the menstrual cycle, maintaining pregnancy, and preparing the endometrium for embryo implantation. Gestgain SR 200 is commonly prescribed for conditions such as luteal phase deficiency, amenorrhea, abnormal uterine bleeding, and as part of hormone replacement therapy in menopausal women. It is also utilized in assisted reproductive technologies to support early pregnancy. The natural micronized form enhances bioavailability and mimics endogenous progesterone activity, reducing the risk of adverse effects associated with synthetic progestins. Patients should follow prescribed dosing regimens and consult healthcare providers regarding contraindications, including hormone-sensitive cancers, liver dysfunction, and thromboembolic disorders. Common side effects may include headache, dizziness, breast tenderness, and mild gastrointestinal disturbances. Gestgain SR 200 should be used under strict medical supervision to ensure optimal outcomes and minimize potential risks associated with hormone therapy.